Related Experiment Videos
[Ofloxacin (RU 43280). Clinical study].
Pathologie-Biologie
|May 1, 1987
Summary
Ofloxacin demonstrated good efficacy in treating various severe bacterial infections, including pneumonitis and urinary tract infections, with no severe adverse effects observed in 32 patients. This fluoroquinolone antibiotic is a valuable option for complex infections.
Area of Science:
- Infectious Diseases
- Pharmacology
- Microbiology
Context:
- Ofloxacin is a broad-spectrum fluoroquinolone antibiotic.
- Bacteriological documented infections were treated in 32 patients.
- Many patients had severe infections, including bacteremia and meningitis.
Purpose:
- To evaluate the efficacy and safety of ofloxacin in treating various documented bacterial infections.
- To assess ofloxacin's effectiveness as a primary or salvage therapy.
- To document the clinical outcomes and adverse effects of ofloxacin treatment.
Summary:
- Ofloxacin was administered orally (400-800 mg/day) to 32 patients with documented infections.
- Effective outcomes were observed in pneumonitis, urinary tract infections, osteoarticular infections, and rickettsial infections.
- The treatment showed good results in severe cases, including bacteremia and meningitis, with no severe adverse effects.
Impact:
- Ofloxacin is effective for treating a range of severe bacterial infections.
- The antibiotic is well-tolerated, even in complex cases.
- Results support the use of ofloxacin in clinical practice for documented infections.